DENTALCORP HOLDINGS LTD (DNTL.CA) Stock Fundamental Analysis
TSX:DNTL - CA24874B1085 - Common Stock
8.24 CAD
+0.09 (+1.1%)
Overall DNTL gets a fundamental rating of 4 out of 10. We evaluated DNTL against 15 industry peers in the Health Care Providers & Services industry. DNTL has a medium profitability rating, but doesn't score so well on its financial health evaluation. DNTL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DNTL was profitable.
DNTL had a positive operating cash flow in the past year.
DNTL had negative earnings in each of the past 5 years.
DNTL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
DNTL has a Return On Assets (-1.32%) which is comparable to the rest of the industry.
DNTL has a Return On Equity of -2.55%. This is comparable to the rest of the industry: DNTL outperforms 60.00% of its industry peers.
DNTL has a Return On Invested Capital (1.47%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for DNTL is significantly below the industry average of 7.83%.
The last Return On Invested Capital (1.47%) for DNTL is above the 3 year average (0.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.32% | ||
| ROE | -2.55% | ||
| ROIC | 1.47% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
1.3 Margins
DNTL's Operating Margin of 4.06% is fine compared to the rest of the industry. DNTL outperforms 66.67% of its industry peers.
DNTL's Operating Margin has improved in the last couple of years.
DNTL has a better Gross Margin (50.03%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of DNTL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.06% | ||
| PM (TTM) | N/A | ||
| GM | 50.03% |
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DNTL is destroying value.
Compared to 1 year ago, DNTL has more shares outstanding
Compared to 5 years ago, DNTL has more shares outstanding
Compared to 1 year ago, DNTL has an improved debt to assets ratio.
2.2 Solvency
DNTL has an Altman-Z score of 0.81. This is a bad value and indicates that DNTL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.81, DNTL is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
The Debt to FCF ratio of DNTL is 8.58, which is on the high side as it means it would take DNTL, 8.58 years of fcf income to pay off all of its debts.
DNTL has a better Debt to FCF ratio (8.58) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that DNTL is somewhat dependend on debt financing.
DNTL has a Debt to Equity ratio (0.77) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.58 | ||
| Altman-Z | 0.81 |
ROIC/WACC0.18
WACC8.01%
2.3 Liquidity
A Current Ratio of 0.98 indicates that DNTL may have some problems paying its short term obligations.
With a decent Current ratio value of 0.98, DNTL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
A Quick Ratio of 0.83 indicates that DNTL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.83, DNTL is in line with its industry, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.86% over the past year.
The Revenue has grown by 9.94% in the past year. This is quite good.
DNTL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.02% yearly.
EPS 1Y (TTM)20.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.5%
Revenue 1Y (TTM)9.94%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%8.85%
3.2 Future
Based on estimates for the next years, DNTL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.34% on average per year.
Based on estimates for the next years, DNTL will show a small growth in Revenue. The Revenue will grow by 7.80% on average per year.
EPS Next Y12.95%
EPS Next 2Y13.85%
EPS Next 3Y10.34%
EPS Next 5YN/A
Revenue Next Year10.41%
Revenue Next 2Y10.44%
Revenue Next 3Y6.19%
Revenue Next 5Y7.8%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.62, the valuation of DNTL can be described as rather expensive.
Based on the Price/Earnings ratio, DNTL is valued a bit cheaper than 80.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.06, DNTL is valued a bit cheaper.
The Price/Forward Earnings ratio is 15.51, which indicates a correct valuation of DNTL.
Based on the Price/Forward Earnings ratio, DNTL is valued cheaper than 86.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, DNTL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.62 | ||
| Fwd PE | 15.51 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DNTL indicates a somewhat cheap valuation: DNTL is cheaper than 80.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DNTL indicates a somewhat cheap valuation: DNTL is cheaper than 80.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.73 | ||
| EV/EBITDA | 10.84 |
4.3 Compensation for Growth
DNTL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.52
PEG (5Y)N/A
EPS Next 2Y13.85%
EPS Next 3Y10.34%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.23%, DNTL has a reasonable but not impressive dividend return.
DNTL's Dividend Yield is a higher than the industry average which is at 3.35.
With a Dividend Yield of 1.23, DNTL pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.23% |
5.2 History
DNTL does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y13.85%
EPS Next 3Y10.34%
TSX:DNTL (9/5/2025, 7:00:00 PM)
8.24
+0.09 (+1.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.96%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap1.57B
Analysts83.53
Price Target12.91 (56.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.23% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.93%
Min EPS beat(2)-32.39%
Max EPS beat(2)-9.48%
EPS beat(4)1
Avg EPS beat(4)-23.69%
Min EPS beat(4)-69.72%
Max EPS beat(4)16.81%
EPS beat(8)4
Avg EPS beat(8)-13.63%
EPS beat(12)6
Avg EPS beat(12)-10.83%
EPS beat(16)8
Avg EPS beat(16)3.02%
Revenue beat(2)0
Avg Revenue beat(2)-1.64%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)-0.81%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)0.06%
Revenue beat(8)1
Avg Revenue beat(8)-1.8%
Revenue beat(12)2
Avg Revenue beat(12)-1.39%
Revenue beat(16)3
Avg Revenue beat(16)-1.27%
PT rev (1m)-0.52%
PT rev (3m)-0.52%
EPS NQ rev (1m)8.19%
EPS NQ rev (3m)57.14%
EPS NY rev (1m)-10%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-1.43%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.62 | ||
| Fwd PE | 15.51 | ||
| P/S | 0.97 | ||
| P/FCF | 9.73 | ||
| P/OCF | 7.14 | ||
| P/B | 0.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.84 |
EPS(TTM)0.42
EY5.1%
EPS(NY)0.53
Fwd EY6.45%
FCF(TTM)0.85
FCFY10.28%
OCF(TTM)1.15
OCFY14%
SpS8.47
BVpS9.28
TBVpS-4.32
PEG (NY)1.52
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.32% | ||
| ROE | -2.55% | ||
| ROCE | 2.04% | ||
| ROIC | 1.47% | ||
| ROICexc | 1.51% | ||
| ROICexgc | 8.71% | ||
| OM | 4.06% | ||
| PM (TTM) | N/A | ||
| GM | 50.03% | ||
| FCFM | 9.99% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
ROICexc(3y)0.6%
ROICexc(5y)N/A
ROICexgc(3y)3.44%
ROICexgc(5y)N/A
ROCE(3y)0.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y24.24%
ROICexc growth 3YN/A
ROICexc growth 5Y27.79%
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.58 | ||
| Debt/EBITDA | 5.1 | ||
| Cap/Depr | 29.29% | ||
| Cap/Sales | 3.62% | ||
| Interest Coverage | 0.75 | ||
| Cash Conversion | 82.84% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 0.81 |
F-Score6
WACC8.01%
ROIC/WACC0.18
Cap/Depr(3y)18.24%
Cap/Depr(5y)15.74%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.5%
EPS Next Y12.95%
EPS Next 2Y13.85%
EPS Next 3Y10.34%
EPS Next 5YN/A
Revenue 1Y (TTM)9.94%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%8.85%
Revenue Next Year10.41%
Revenue Next 2Y10.44%
Revenue Next 3Y6.19%
Revenue Next 5Y7.8%
EBIT growth 1Y76.14%
EBIT growth 3YN/A
EBIT growth 5Y36.31%
EBIT Next Year85.75%
EBIT Next 3Y31.11%
EBIT Next 5Y19.8%
FCF growth 1Y69.39%
FCF growth 3Y58.7%
FCF growth 5Y157.47%
OCF growth 1Y68.86%
OCF growth 3Y52.18%
OCF growth 5Y50.41%